1. Home
  2. FNWD vs ARCT Comparison

FNWD vs ARCT Comparison

Compare FNWD & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$42.77

Market Cap

187.1M

Sector

Finance

ML Signal

N/A

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$14.05

Market Cap

163.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
ARCT
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
163.4M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
FNWD
ARCT
Price
$42.77
$14.05
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$37.50
$24.11
AVG Volume (30 Days)
8.4K
1.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
1.51%
N/A
EPS Growth
N/A
20.00
EPS
1.00
N/A
Revenue
N/A
$82,031,000.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
$12.77
P/E Ratio
$42.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$5.50
52 Week High
$45.90
$24.14

Technical Indicators

Market Signals
Indicator
FNWD
ARCT
Relative Strength Index (RSI) 45.08 51.75
Support Level $34.83 $6.47
Resistance Level $44.22 $17.75
Average True Range (ATR) 0.60 1.37
MACD -0.19 -0.39
Stochastic Oscillator 16.59 20.66

Price Performance

Historical Comparison
FNWD
ARCT

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: